In addition, either in primary or metastatic breast cancers, ER-negative/HER2-positive breast cancers have shown poor survival than ER-positive/HER2-positive ones (37), suggesting that the outcome of bone metastatic breast cancer may be dependent on both HR and HER2 statuses of the primary tumor. The gene discussed is ERBB2; the disease is neoplasm.